Suven Life Sciences Ltd’s Net Up by 50%, Spends 17% of Revenue on R&D

HYDERABAD, INDIA (October 31, 2008) – SUVEN LIFE Sciences Limited is a biopharmaceutical company specializing in Central Nervous System diseases, today announced its unaudited financial results for the quarter ended Sep 2008. The unaudited financial results were reviewed by the audit committee and approved by the Board of Directors in their meeting held on Oct 31, 2008 at Hyderabad

MORE ON THIS TOPIC